Paris, France

Daniel Dauzonne

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2008-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Dauzonne

Introduction

Daniel Dauzonne is a notable inventor based in Paris, France. He has made significant contributions to the field of antiviral agents through his innovative research and development. With a total of 2 patents, Dauzonne's work has the potential to impact the medical community positively.

Latest Patents

Dauzonne's latest patents include groundbreaking inventions aimed at combating viral infections. The first patent focuses on derivatives useful as antiviral agents. This invention relates to compounds of formula (I) designed for the prevention and/or treatment of viral infections, with specific groups defined in the claims. The second patent involves 9-amino-podophyllotoxin derivatives, detailing a method for their production and pharmaceutical compositions containing these derivatives. This invention also specifies various groups and compounds that enhance its effectiveness.

Career Highlights

Throughout his career, Daniel Dauzonne has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Les Laboratoires Servier. His experience in these institutions has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Dauzonne has collaborated with notable colleagues, including Claude Monneret and John Hickman. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Daniel Dauzonne's contributions to the field of antiviral agents through his patents and collaborations highlight his dedication to advancing medical science. His work continues to inspire future innovations in the fight against viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…